Pilot Study To Evaluate Optical Frequency Domain Imaging For Diagnosis Of Central Airway Disease

Withdrawn before enrolling · Not applicable

Conditions studied: Squamous Cell Lung Cancer, Lung Cancer, Pulmonary Disease

In brief

To evaluate the potential of a new imaging device, termed Optical Frequency Domain Imaging (OFDI), in the early diagnosing of pulmonary malignancies in the central airways.

Key facts

Study ID

NCT00784329

Run by

Lahey Clinic

People needed

0

Starts

2008-03-01

Expected to finish

2018-12-01

Last updated by the study team

2019-03-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing bronchoscopy for known or suspected pulmonary malignancy in the central airways
• Patients must be over the age of 18
• Patient must be able to give informed consent
• Women with child bearing potential must have a negative pregnancy test within seven days prior to the procedure

You may not qualify if…

• PaO2 less than 80 on FiO2 greater 70%
• Systolic blood pressure less than 90
• Active bronchospasm
• INR greater than 2.0 (INR: International Normalized Ratio)
• Recent myocardial infarction within last two weeks
• Active cardiac chest pain
• Significant untreated sleep apnea
• FEV1 less than 30% of predicted (FEV1: forced expiratory volume in 1 second)
• Worsening hypercarbia with PaCO2 greater than 55
• In active respiratory failure (unless endotracheal intubation is performed first to stabilize the airway)

Where it is running

• Lahey Clinic, Inc. — Burlington, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.